Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
88 hedge funds and large institutions have $173M invested in Vaxart in 2020 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.
600% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 8
222% more capital invested
Capital invested by funds: $53.9M → $173M (+$119M)
120% more funds holding
Funds holding: 40 → 88 (+48)
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16.59% less ownership
Funds ownership: 43% → 26.42% (-17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$8.9M |
| 2 |
BlackRock
New York
|
+$8.18M |
| 3 |
VA
VR Adviser
New York
|
+$7.94M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$4.71M |
| 5 |
Millennium Management
New York
|
+$2.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$72M |
| 2 |
Renaissance Technologies
New York
|
-$4.47M |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$862K |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
-$119K |
| 5 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$88K |
VXRT Hedge Fund Activity: Q2 2020 in Review
88 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2020, worth a combined $173M — up 222% from $53.9M a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new VXRT positions and 8 closed out — a net gain of 48 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $8.9M. The largest seller was Armistice Capital, cutting an estimated $72M.
- 88 institutional investors held Vaxart (VXRT) as of Q2 2020, up from 40 in Q1 2020.
- Funds reported $173M of Vaxart stock for Q2 2020, up 222% quarter-over-quarter.
- 56 funds opened new Vaxart positions in Q2 2020 and 8 closed out, a net change of +48 holders.
- The largest Vaxart buyer in Q2 2020 was Citadel Advisors, an estimated $8.9M added.
- The largest Vaxart seller in Q2 2020 was Armistice Capital, an estimated $72M sold.
Based on aggregated 13F filings for Q2 2020.